HER2 MUTATION
Clinical trials for HER2 MUTATION explained in plain language.
Never miss a new study
Get alerted when new HER2 MUTATION trials appear
Sign up with your email to follow new studies for HER2 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes on hard-to-treat lung cancer in major trial
Disease control Recruiting nowThis phase 3 study tests a new daily pill, sevabertinib, against standard intravenous chemotherapy for people with advanced non-small cell lung cancer that has specific HER2 mutations. About 444 adults will be randomly assigned to receive either the pill or standard treatment. Th…
Matched conditions: HER2 MUTATION
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New pill targets HER2 cancers in promising trial
Disease control Recruiting nowThis study tests an oral drug called BAY 2927088 (sevabertinib) in adults with advanced solid tumors that have HER2 gene mutations. The drug aims to block the abnormal HER2 protein and slow or shrink the cancer. About 111 participants will take the drug daily until their cancer w…
Matched conditions: HER2 MUTATION
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated May 11, 2026 20:48 UTC